Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Montag, 28.05.2012Börsentäglich über 11.000 News von 416 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

TOPOTARGET

WKN: A0ERXB  ISIN: DK0060003556  Ticker-Symbol: T5I 
Aktie:
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
TOPOTARGET Chart 1 Jahr
1-Woche-Intraday-Chart
TOPOTARGET 1-Woche-Intraday-Chart

Aktuelle News zur TOPOTARGET Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
25.05. 25
To NASDAQ OMX Copenhagen A/S Investor News No. 03-12 / Copenhagen, May 25, 2012 Copenhagen, Denmark - May 25, 2012 - Today Topotarget A/S (NASDAQ OMX: TOPO) announced that a telephone conference will...
Mehr lesen zu:
Topotarget: Time and date for telephone conference related to the publishing of the interim report for Q1 2012
17.05. 64
To NASDAQ OMX Copenhagen A/S Announcement No. 08-12 / Copenhagen, May 17, 2012 Copenhagen, Denmark - May 17, 2012 - Today Topotarget A/S (NASDAQ OMX: TOPO) announced that abstracts on belinostat clinical...
Mehr lesen zu:
Topotarget: Clinical data on belinostat for ASCO 2012
02.05. 17
To NASDAQ OMX Copenhagen A/S Announcement No. 07-12 / Copenhagen, 2 May, 2012 Copenhagen, Denmark - 2 May, 2012 - Topotarget A/S (NASDAQ OMX: TOPO) has announced that 1,025,000 warrants have been...
Mehr lesen zu:
Topotarget: Topotarget issues warrants to Employees, Management and Board of Directors
11.04. 27
To NASDAQ OMX Copenhagen A/S Announcement No. 06-12 / Copenhagen, April 11, 2012 Copenhagen, Denmark - April 11, 2012 - Topotarget A/S (NASDAQ OMX: TOPO) held its Annual General Meeting today at Symbion...
Mehr lesen zu:
Topotarget: Passing on Topotarget A/S Annual General Meeting
19.03. 27
To NASDAQ OMX Copenhagen A/S Announcement No. 05-12 / Copenhagen, March 19, 2012 Notice is hereby given that the Annual General Meeting of Topotarget A/S will be held on: Wednesday April 11, 2012...
Mehr lesen zu:
Topotarget: Notice to Convene Annual General Meeting
14.03. 40
To NASDAQ OMX Copenhagen A/S Announcement No. 04-12 / Copenhagen, March 14, 2012 Copenhagen, Denmark - March 14, 2012 - Today Topotarget A/S (NASDAQ OMX: TOPO) announced the financial results for...
Mehr lesen zu:
Topotarget: CORRECTION: Topotarget announces financial results for the year ended December 31, 2011
14.03. 51
To NASDAQ OMX Copenhagen A/S Announcement No. 04-12 / Copenhagen, March 14, 2012 Copenhagen, Denmark - March 14, 2012 - Today Topotarget A/S (NASDAQ OMX: TOPO) announced the financial results for...
Mehr lesen zu:
Topotarget: Topotarget announces financial results for the year ended December 31, 2011
09.03. 34
To NASDAQ OMX Copenhagen A/S Investor News No. 02-12 / Copenhagen, March 9, 2012 Copenhagen, Denmark - March 9, 2012 - Topotarget A/S (NASDAQ OMX: TOPO) announces that a teleconference will be held...
Mehr lesen zu:
Topotarget: Topotarget announces the time and date for the telephone conference related to the publishing of the annual report 2011
29.02. 89
Copenhagen, Denmark - February 29, 2012 - Today Topotarget A/S (NASDAQ OMX: TOPO) announced that clinical data on belinostat will be presented at the 2012 American Association for Cancer Research...
Mehr lesen zu:
Topotarget: Abstract for the American Association for Cancer Research 2012
24.02. 27
Copenhagen, 24 February 2012 Disclosure of price sensitive information in a press release NASDAQ OMX Copenhagen has given a reprimand to Topotarget A/S as the information in the company's press release...
Mehr lesen zu:
NASDAQ OMX Copenhagen A/S: Reprimand to Topotarget
18.01. 50
Copenhagen, 2012-01-18 11:01 CET (GLOBE NEWSWIRE) -- Copenhagen, Denmark - January 18, 2012 - Today Topotarget A/S (NASDAQ OMX: TOPO.CO) announced that clinical data on belinostat will be presented...
Mehr lesen zu:
Topotarget: Abstract for ASCO Gastrointestinal Cancers Symposium 2012
05.01. 29
Copenhagen, Denmark - January 5, 2012 - Topotarget A/S (NASDAQ-OMX: TOPO.CO) incorrectly announced the company's two recent announcements related to the divestment of Totect® to Apricus Biosciences...
Mehr lesen zu:
Topotarget: Topotarget A/S formalizes previous announcements regarding the divestiture of Totect®
29.12. 88
WASHINGTON (dpa-AFX) - Apricus Biosciences Inc.(APRI) announced the closing of its acquisition of Topotarget USA Inc., a subsidiary of Topotarget A/S, a Danish company listed on the Copenhagen...
Mehr lesen zu:
Apricus Biosciences Closes Acquisition Of Topotarget USA
29.12. 3
29.12. 76
To Rename the Newly Acquired Company, Apricus Pharmaceuticals USA, Inc. SAN DIEGO, Dec. 29, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (http://www.apricusbio.com)...
Mehr lesen zu:
Apricus Biosciences, Inc.: Apricus Biosciences Completes Acquisition of Topotarget USA, Inc.
29.12. 64
Copenhagen, Denmark - December 30, 2011 - Topotarget A/S (NASDAQ-OMX: TOPO.CO) has today announced the completion of Apricus Biosciences, Inc.'s purchase of 100% of the outstanding common stock of...
Mehr lesen zu:
Topotarget: Topotarget A/S announces the successful completion of the divestiture of Totect® and Topotarget USA, Inc to Apricus Biosciences, Inc.
29.12. 120
Apricus Biosciences Completes Acquisition of Topotarget USA, Inc. Apricus Biosciences, Inc. 29.12.2011 18:30 -------------------------------------------------------------------- ------- To...
Mehr lesen zu:
Apricus Biosciences Completes Acquisition of Topotarget USA, Inc.
16.12. 63
WASHINGTON (dpa-AFX) - Apricus Biosciences, Inc. (APRI) said Friday that it has agreed to buy Topotarget USA, Inc., a subsidiary of Topotarget A/S. Topotarget USA owns Totect, the only drug...
Mehr lesen zu:
Apricus Biosciences To Buy Topotarget USA
16.12. 14
First Acquisition by Apricus Bio of an FDA Approved and Marketed US Drug SAN DIEGO, 2011-12-16 14:00 CET (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) announced...
Mehr lesen zu:
Apricus Biosciences, Inc.: Apricus Biosciences Launches Commercialization Arm With Definitive Agreement to Acquire Topotarget USA
16.12. 28
Copenhagen, Denmark - December 16, 2011 - Topotarget A/S (NASDAQ-OMX: TOPO.CO) has announced today that Apricus Biosciences, Inc. has entered into an agreement to purchase 100% of the outstanding...
Mehr lesen zu:
Topotarget: Topotarget A/S announces the divestiture of Totect® to Apricus Biosciences, Inc., and improved financial expectations for 2011
Seite: 1 2 Weiter>>
22 Nachrichten in den letzten 6 Monaten